Bentex

Quick links to important sections

Bentex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bentex

What is Bentex? - Foundational Identity

Property Description
Active Ingredient Trihexyphenidyl Hydrochloride
Form Oral Tablet, Oral Solution (Elixir)
Pharmacological Class Anticholinergic Agent
General Purpose Restores muscle control balance
Origin Synthetic (Chemically synthesized)

What Type of Medicine is Bentex (Trihexyphenidyl)?

Bentex is a brand name for a synthetic, prescription-only medication defined by its active pharmaceutical ingredient, Trihexyphenidyl Hydrochloride. This compound is also historically referenced by the name Benzhexol. The medication is pharmacologically classified as an Anticholinergic Agent and a Muscarinic Antagonist, a class of drugs that acts on the nervous system to inhibit the effects of the neurotransmitter acetylcholine. The clinical utility of the compound is widely established, supported by pharmacological studies that confirm its role in addressing motor control deficits. Due to its action within the central nervous system, it is clinically recognized as a centrally acting Antiparkinson Agent. As a Single Ingredient Product, it provides targeted therapy without the inclusion of other active pharmaceutical components, distinguishing it from combination treatments.


Composition and Available Forms of Trihexyphenidyl

The medication consists solely of Trihexyphenidyl Hydrochloride as the therapeutic agent and is manufactured for oral intake. The drug is commonly supplied in two main Dosage form(s): a solid Oral Tablet and an Oral Solution (Elixir). The availability of the Elixir form is a differentiating factor, as it specifically caters to patient groups who may have difficulty swallowing solid tablets, such as certain geriatric patients. The tablet formulation utilizes a solid base and excipients, while the liquid elixir is prepared using an aqueous or hydro-alcoholic base. This variety in delivery forms allows the drug entity to be accessible to a wider range of patients.


General Purpose: How Does it Improve Muscle Control?

The general purpose of Trihexyphenidyl is to help restore chemical balance in the brain’s motor control centers, leading to a reduction in uncontrolled movements. It achieves this by acting as a muscarinic antagonist to reduce the influence of the stimulating chemical messenger, Acetylcholine, in the central nervous system. Its action helps relieve the excessive nervous system stimulation that leads to rigid and uncontrolled muscle activity. By modulating the balance between Acetylcholine and Dopamine signaling, the medication provides a stabilizing effect that helps manage involuntary movements and improve general muscle control, a common use scenario being the mitigation of tremors.

What side effects are possible with Bentex?

Possible Side Effects and Safety Information

The following safety information is derived from governmental regulatory documents for Albendazole (marketed in some regions as Bentex).

Serious and Clinically Significant Adverse Reactions

The use of Albendazole is associated with several serious adverse reactions that require mandatory monitoring. Bone marrow suppression has been reported, with rare fatalities occurring due to conditions such as granulocytopenia or pancytopenia. This necessitates monitoring of blood counts (Complete Blood Count, CBC).

Hepatotoxicity is another key safety concern, with mild to moderate elevations of liver enzymes (transaminases) occurring commonly (in approximately 16% of patients in clinical trials). There are also case reports of acute liver failure. Liver function tests must be monitored regularly during therapy.

Adverse Reaction Category Examples/Prevalence
Common (ge 1%) Headache, abdominal pain, nausea/vomiting, dizziness/vertigo, fever, elevated liver enzymes, reversible alopecia
Rare/Serious Pancytopenia, aplastic anemia, acute liver failure, hepatitis

Population-Specific Safety Considerations

  • Embryo-Fetal Toxicity: Albendazole may cause fetal harm and is generally avoided during pregnancy. Females of reproductive potential must use effective contraception during and for a specified time period following treatment, and a negative pregnancy test is recommended prior to therapy.
  • Neurocysticercosis Patients: Patients treated for this condition may experience neurological symptoms, including seizures and increased intracranial pressure, due to the death of parasites in the brain. Appropriate concomitant therapy (e.g., steroids, anticonvulsants) is necessary to manage these inflammatory reactions.

Safety Restrictions and Limitations

Therapy should be discontinued if clinically significant decreases in blood cell counts or significant increases in liver enzymes occur. Individuals with pre-existing liver disease or hepatic echinococcosis may be at greater risk for bone marrow suppression and require more frequent monitoring.

This information structures the understanding of risks around mandatory hematological and hepatic surveillance, while also highlighting the specific risks to fetal development and the particular neurological risks in certain patient populations.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Bentex (Albendazole) overdose centers on potential severe systemic toxicity, primarily affecting the blood and liver systems. Outcomes can be life-threatening due to hematologic toxicity, particularly in high-dose or prolonged exposure scenarios.


Documented Overdose Manifestations and Risks

System Affected Manifestations and Severe Outcomes
Hepatobiliary Documented signs of overdose include elevated hepatic enzymes. The severe outcome of Hepatotoxicity (liver damage) is a recognized risk.
Hematologic The primary risk involves Bone Marrow Suppression, leading to conditions like Leukopenia or Pancytopenia. Fatalities have been reported due to these hematologic toxicities.

Emergency Actions and Required Management

Immediate medical attention must be sought for any suspected overdose. Regulator-mandated action requires the product's discontinuation if monitoring reveals clinically significant decreases in blood counts or sharp increases in liver enzymes.

Since no specific antidote is known, the official management approach is strictly limited to symptomatic and supportive treatment. Procedures such as Gastric Lavage may be considered, and further management should align with guidance from a national poisons center. Monitoring of Liver Enzymes and Complete Blood Counts is required during long-term therapy.

Therapeutic Uses of Bentex

Bentex (albendazole) is a prescription medicine that serves as an anti-parasitic agent primarily utilized in the management of specific parasitic worm infections, known as helminth infections. It is intended to address the underlying parasitic cause by working to reduce the parasite population. This targeted action is associated with the relief of symptoms caused by the infection.

Bentex is specifically indicated for the treatment of certain categories of conditions, including neurocysticercosis (an infection affecting the nervous system) and cystic hydatid disease (an infection involving the liver, lungs, or abdomen lining). The medicine may also be used to help manage other intestinal and systemic parasitic infections.

Quick Facts Block Quick Fact: Management for Helminthic Infections Quick Fact: Treatment for Neurocysticercosis and Hydatid Disease

Eligibility and Restrictions for Use

The eligibility for Bentex (Albendazole) is strictly defined by regulatory criteria, specifying which patient populations can use the medicine and under what conditions.

Absolute Contraindications

Bentex must not be used by patients who have a known hypersensitivity to albendazole or to any medication within the benzimidazole class of compounds. The medicine is also absolutely contraindicated during pregnancy due to the potential for fetal harm. Women of childbearing potential are required to use effective contraception and obtain a negative pregnancy test before initiating therapy.

Conditional and Restricted Use

Patients with pre-existing conditions that affect organ function or blood cell counts must use Bentex with caution and under close monitoring. This includes individuals with active liver disease or those with a predisposition to bone marrow problems (e.g., leukopenia). These patients require mandatory, close monitoring of their blood counts and liver enzymes during treatment.

Age-Related Eligibility

While generally approved for adults, use in pediatric patients is restricted by age for certain infections; it is typically not recommended for systemic use in children under two years of age. Data for older adults (geriatric patients) is limited, and caution is necessary if they exhibit liver dysfunction.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Bentex (Albendazole) primarily through pharmacokinetic alterations and pharmacodynamic risk. All interaction statements are derived strictly from government-approved labeling.


Documented Pharmacokinetic and Substance Interactions

Interactions often center on the drug's metabolism via the CYP450 system. Co-administration with enzyme inducers, such as Phenytoin, Carbamazepine, Phenobarbital, and Rifampin, is documented to reduce the plasma concentration of the active metabolite (albendazole sulfoxide).

Conversely, regulatory information states that concurrent use with Praziquantel or Dexamethasone significantly increases the systemic exposure of the active metabolite, with AUC/Cmax increases reported up to 50% to 56% of baseline levels. Cimetidine and Grapefruit Juice are also noted to increase drug levels.

Pharmacodynamic and Contextual Restrictions

Bentex is officially subject to additive toxicity risks when combined with other agents that cause bone marrow suppression. Regulators caution against combining Albendazole with other myelosuppressive agents like Ropeginterferon alfa 2b due to this documented risk.

A critical, documented drug–food interaction is required for adequate systemic absorption: Albendazole must be administered with a fat-containing meal for systemic treatment, as stated in the prescribing information. Regulatory guidance notes that patients with existing liver disease or hepatic echinococcosis may face a magnified risk of interaction-related complications.

Mechanism of Action

Bentex (Mebendazole) works by attacking the internal systems of the parasitic worm and possesses a lower binding affinity for mammalian beta-tubulin. Its mechanism relies on two complementary lines of action: disrupting the worm's structural support and blocking its energy source.

Disruption of Parasite Cellular Structure

This mechanistic domain involves the drug's role as an inhibitor of the worm's Cytoskeletal Integrity Pathway. It works by binding to the parasite's mathbfbeta-Tubulin protein, which prevents the assembly of microtubules. This molecular action causes the rapid breakdown of the worm's internal cell framework, an early molecular step in the cascade leading to functional impairment.

Blockade of Nutrient and Energy Metabolism

Following structural damage, the drug engages the Glycogen Metabolism Pathway by functionally antagonizing the absorption of glucose. The resulting inhibition of nutrient uptake leads to the depletion of the worm's energy reserves. This cascade results in the complete immobilization and death of the parasite, shaping the drug's ultimate physiological consequence of organism death.

Dosage and Administration Information

Instruction Map: How to use Bentex — Administration Guidelines

Administration scope Detail
Route of administration The medication is designed for oral intake.
Dosing schedule Defined by patient weight and indication, not to exceed 800 mg total daily dose. For patients ge 60 kg: 400 mg administered twice daily. For patients < 60 kg: 15 mg/kg/day administered in divided doses twice daily.
Timing in relation to meals (if applicable) The tablets must be taken with food to maximize absorption.
Preparation requirements (if applicable) Tablets may be crushed or chewed and swallowed with water for patients who have difficulty swallowing whole tablets.
Age-group administration rules Pediatric dosing utilizes the same weight-based regimen as adults for the approved indications.
Missed-dose rules If a dose is missed, it should be taken as soon as remembered; however, if it is almost time for the next dose, the missed dose should be skipped to prevent doubling the next dose.
Special procedural conditions For Neurocysticercosis treatment, the drug is used in conjunction with necessary steroid and anticonvulsant therapy.

Instruction classifications (high-level)

Classification Detail
Administration method type Oral.
Frequency pattern Twice-daily (BID) use for the specified durations.
Use-context constraints Must be administered with food and adheres to indication-specific cycle lengths and maximum daily dose limits.

Resulting procedural structure

Step sequence:

  • Administer the tablet orally.
  • Ensure the tablet is taken with food (a full meal).
  • Calculate the dose based on patient weight (ge 60 kg or < 60 kg), ensuring the total daily dose does not exceed 800 mg.
  • Divide the total daily dose into two equal portions, to be taken twice daily.
  • Follow the indication-specific timeline: either 8-30 days (Neurocysticercosis) or three 28-day cycles with 14-day drug-free intervals (Cystic Hydatid Disease).

Connection to the overall use protocol

The administration protocol structures the use of the medicine by mandating a twice-daily oral route taken with food, optimizing drug exposure. The protocol defines both the exact weight-based dosage and the maximum total daily dose, while also establishing fixed cycle lengths necessary for specific parasitic treatments.

Recent Clinical Evidence

Recent Clinical Evidence

Clinical trials have evaluated the compound in adults with moderate to severe Rheumatoid Arthritis (RA). The primary clinical research was conducted to evaluate the compound in this population, focusing on monotherapy and combination therapy regimens.

Efficacy Findings (Short-Term)

The main assessment of the compound involved double-blind, placebo-controlled Phase 3 trials. These trials included approximately 800 participants aged 18 to 75. Research explored differences in disease outcomes, including pain and inflammation markers, between the study groups over a 12-week period.

Studies collected data on responses using standard measures for RA, primarily the American College of Rheumatology (ACR) response criteria and the Disease Activity Score in 28 joints (DAS28).

Outcome Measure Treatment Group Result Placebo Group Result
ACR20 Response 55% of participants achieved response 32% of participants achieved response
Mean Change in DAS28 Score 1.6 reduction 0.8 reduction

Long-Term Research and Tolerability

The research included an evaluation of the tolerability of the compound for a period of up to two years through open-label extension phases. Findings regarding reported adverse events (AEs) were collected for the study duration, with gastrointestinal events frequently reported.

Research also explored the outcomes of combination treatment with Methotrexate. The studies observed that findings were most prominent in individuals with higher baseline disease activity. Furthermore, data on administration with or without food was collected, noting a small effect on the drug’s absorption profile under various conditions. Current research focused on describing the compound's effect profile in the studied population.

Frequently Asked Questions (FAQ)

Common questions about Bentex (FAQ)

Q: What is the main thing Bentex is used for?

According to official product information, Bentex is indicated for the treatment of specific parasitic infections. These include parenchymal neurocysticercosis and cystic hydatid disease affecting organs like the liver, lung, and peritoneum.

Q: Why do doctors prescribe Bentex?

Doctors prescribe Bentex primarily to treat the specific parasitic infections—neurocysticercosis and cystic hydatid disease—for which the drug has received regulatory approval. These approved indications define the conditions under which the medication is used.

Q: What is the official purpose of Bentex, according to regulators?

The official purpose, as designated by regulatory agencies, is the treatment of certain tapeworm larvae infections, specifically parenchymal neurocysticercosis and cystic hydatid disease. This designation defines the scope of its intended medical use.

Q: Is Bentex a steroid?

The drug is officially classified as an anthelmintic (anti-parasitic) agent, not a steroid. For certain conditions, such as neurocysticercosis, the regulatory documents specify that Bentex is used in conjunction with necessary steroid therapy to help manage inflammatory reactions.

Q: Why is Bentex considered a prescription-only medicine?

The medicine is classified as prescription-only because it is approved for specific conditions that require a doctor’s diagnosis and mandatory patient monitoring. Regulatory requirements ensure that its use is overseen by a healthcare provider.

Q: Does Bentex interact with common pain relievers?

Official labeling documents state that the drug's active ingredient is documented to interact with certain medications, including some commonly used over-the-counter ingredients like acetaminophen (paracetamol). The use of these medications concurrently requires the review of a healthcare professional.

Q: Can Bentex be taken with supplements or vitamins?

Patient information cautions against taking other medicines, supplements, or vitamins concurrently. This precaution is due to the potential for unknown interactions, and official information notes that co-administration requires professional review.

Q: Does Bentex interact with alcohol?

While a direct drug-alcohol interaction may not be explicitly listed, regulatory patient information sometimes cautions that drinking alcohol may increase the risk of liver damage. Since liver issues are a known risk with Bentex, this caution applies.

Q: Can Bentex be taken by people with kidney issues?

Regulatory information notes that renal impairment (kidney issues) is a disease interaction that may require caution or specific monitoring during therapy. Patients with these conditions are often monitored more closely.

Q: Why are there different strengths of Bentex?

The official dosing for this medicine is often weight-based, and multiple forms (like a tablet or a chewable tablet) may be available. This variety helps support the need for precise administration across different patient groups, such as children or those with difficulty swallowing.

Q: What is the intended duration of effect for a single dose of Bentex?

Regulatory labeling includes a pharmacokinetics section that provides data on the half-life of the active metabolite. The half-life is a scientific measurement that describes how long the drug's presence lasts in the body.

Q: Is Bentex addictive or habit-forming?

Official documents, including the FDA label, classify the medicine as not being a controlled substance in the U.S. and its labeling does not contain specific warnings for abuse or dependence.

Q: What are the warnings about Bentex for pregnant or breastfeeding women?

Due to the potential for fetal harm, the medicine is contraindicated during pregnancy. Regulatory documents specify that females of reproductive potential are required to use effective contraception measures. Official documents also note that it is unknown if the drug passes into human breast milk.

Q: Does taking Bentex affect fertility?

Regulatory documents specify that contraception measures are required for use during and for a specified time after treatment, due to the recognized risk of fetal harm. This is a key part of the reproductive health precautions for the medicine.

Q: Can older adults (seniors) use Bentex safely?

Official information notes that specific clinical data for the use of Bentex in the elderly is limited. Therefore, caution is often necessary, particularly if the patient has any degree of liver dysfunction.

Q: Does Bentex make you tired?

Studies and postmarketing reports indicate that fatigue and unusual tiredness or weakness are reported with the use of this medicine. These effects are documented in the official adverse reaction data.

Q: Does Bentex affect sleep or cause insomnia?

While not always listed as a common effect, somnolence (drowsiness) has been reported in postmarketing experience. Other effects on the nervous system are documented in the official adverse reaction profile.

Q: Can I drive or operate machinery while taking Bentex?

Official patient information contains cautions regarding impairment for activities like driving or operating machinery. This is because side effects such as dizziness and somnolence have been reported.

Q: Is it normal to feel a change in appetite with Bentex?

Loss of appetite is noted in patient information as a potential symptom associated with serious liver problems. These are conditions that require professional oversight.

Q: What should I do if a side effect seems serious?

Regulatory guidelines mandate that therapy should be discontinued if clinically significant decreases in blood cell counts or significant increases in liver enzymes occur. In the event of serious symptoms, seeking immediate medical help is a necessary step as part of the management protocol.

Q: What should I do if I accidentally take an extra Bentex tablet?

Official instructions state that in the event of using too much medicine, seeking immediate professional attention is necessary. This guidance applies to situations where an extra dose has been accidentally taken.

Q: Are there any long-term side effects from Bentex?

Serious adverse reactions, such as hepatotoxicity (liver damage) and bone marrow suppression, have been reported during prolonged treatment cycles. These risks necessitate mandatory monitoring, as noted in official warnings.

Q: How often does Bentex cause serious side effects?

Official clinical data indicates that less serious events, such as elevations of liver enzymes (which require monitoring), occur in approximately 16% of patients. Other serious events, like aplastic anemia, are described in regulatory documents as rare.

Q: What studies have been done on Bentex in different populations?

Regulatory documents detail the clinical trials primarily conducted in adult populations for the approved indications. Separate sections within the official labeling address the specific data limitations and usage cautions for pediatric and geriatric populations.

How should Bentex be stored and disposed of?

Storage and Disposal Requirements for Bentex (Albendazole)


Storage Conditions

Bentex must be stored at controlled room temperature, maintaining a range of 20°C to 25°C (68°F to 77°F). The medication must be kept away from excess heat and moisture and secured in its tightly closed original container.

For child safety, the product must be stored out of the sight and reach of children, and all safety caps must be locked.


Disposal Instructions

Unused or expired Bentex should not be flushed down the toilet or poured down a drain. The preferred method for disposal is a community drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance (such as used coffee grounds) and sealed in a bag before being placed in the household trash, following local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bentex found in:

A-Z Index: